These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1813774)

  • 1. Proteinase inhibitors.
    Baboonian C; Dalgleish AG
    Mol Aspects Med; 1991; 12(4):329-40. PubMed ID: 1813774
    [No Abstract]   [Full Text] [Related]  

  • 2. Design and synthesis of HIV protease inhibitors containing allophenylnorstatine as a transition-state mimic.
    Kiso Y
    Adv Exp Med Biol; 1995; 362():413-23. PubMed ID: 8540352
    [No Abstract]   [Full Text] [Related]  

  • 3. The evaluation of non-viral substrates of the HIV protease as leads in the design of inhibitors for AIDS therapy.
    Tomasselli AG; Hui JO; Sawyer TK; Thaisrivongs S; Hester JB; Heinrikson RL
    Adv Exp Med Biol; 1991; 306():469-82. PubMed ID: 1812744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of molecular dynamics and free energy perturbation calculations in anti-human immunodeficiency virus drug design.
    McCarrick MA; Kollman P
    Methods Enzymol; 1994; 241():370-84. PubMed ID: 7854189
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral proteases as targets for chemotherapeutic intervention.
    Hellen CU; Wimmer E
    Curr Opin Biotechnol; 1992 Dec; 3(6):643-9. PubMed ID: 1369416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model peptides to study the effects of P2 and P3 substitutions in statine-containing HIV proteinase inhibitors.
    Hui KY; Hermann RB; Manetta JV; Gygi T; Angleton EL
    FEBS Lett; 1993 Aug; 327(3):355-60. PubMed ID: 8348964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of symmetry-based, peptidomimetic inhibitors of human immunodeficiency virus protease.
    Kempf DJ
    Methods Enzymol; 1994; 241():334-54. PubMed ID: 7854187
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitors of HIV-1 protease.
    Meek TD
    J Enzyme Inhib; 1992; 6(1):65-98. PubMed ID: 1285304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.
    Young SD; Payne LS; Thompson WJ; Gaffin N; Lyle TA; Britcher SF; Graham SL; Schultz TH; Deana AA; Darke PL
    J Med Chem; 1992 May; 35(10):1702-9. PubMed ID: 1588552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of tight-binding human immunodeficiency virus type 1 protease inhibitors.
    Vacca JP
    Methods Enzymol; 1994; 241():311-34. PubMed ID: 7854186
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitors of HIV proteinase.
    Martin JA; Redshaw S; Thomas GJ
    Prog Med Chem; 1995; 32():239-87. PubMed ID: 8577919
    [No Abstract]   [Full Text] [Related]  

  • 12. Statine based tripeptides as potent inhibitors of HIV-1 replication.
    Fehrentz JA; Chomier B; Bignon E; Venaud S; Chermann JC; Nisato D
    Biochem Biophys Res Commun; 1992 Oct; 188(2):873-8. PubMed ID: 1445328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interview with Celia Schiffer.
    Schiffer C
    Future Med Chem; 2013 Jul; 5(11):1193-7. PubMed ID: 23859201
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of the protease from human immunodeficiency virus: design and modeling of a compound containing a dihydroxyethylene isostere insert with high binding affinity and effective antiviral activity.
    Thaisrivongs S; Tomasselli AG; Moon JB; Hui J; McQuade TJ; Turner SR; Strohbach JW; Howe WJ; Tarpley WG; Heinrikson RL
    J Med Chem; 1991 Aug; 34(8):2344-56. PubMed ID: 1875334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV protease inhibitors: peptidomimetic drugs and future perspectives.
    Abdel-Rahman HM; Al-karamany GS; El-Koussi NA; Youssef AF; Kiso Y
    Curr Med Chem; 2002 Nov; 9(21):1905-22. PubMed ID: 12369875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 3-D structure of HIV-1 proteinase and the design of antiviral agents for the treatment of AIDS.
    Blundell TL; Lapatto R; Wilderspin AF; Hemmings AM; Hobart PM; Danley DE; Whittle PJ
    Trends Biochem Sci; 1990 Nov; 15(11):425-30. PubMed ID: 2278102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic binding of inhibitors to the protease from HIV type 1.
    Asante-Appiah E; Chan WW
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):113-7. PubMed ID: 8670094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of HIV-1 protease with KNI-272: a transition state mimetic inhibitor containing allophenylnorstatine.
    Baldwin ET; Bhat TN; Gulnik S; Liu B; Kiso Y; Mitsuya H; Erickson JW
    Adv Exp Med Biol; 1995; 362():445-9. PubMed ID: 8540355
    [No Abstract]   [Full Text] [Related]  

  • 20. Potent human immunodeficiency virus type 1 protease inhibitors that utilize noncoded D-amino acids as P2/P3 ligands.
    Jungheim LN; Shepherd TA; Baxter AJ; Burgess J; Hatch SD; Lubbehusen P; Wiskerchen M; Muesing MA
    J Med Chem; 1996 Jan; 39(1):96-108. PubMed ID: 8568831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.